AbbVie (ABBV) Gross Margin (2012 - 2026)
AbbVie (ABBV) posted quarterly Gross Margin of 71.88% for Q1 2026, up 188.0% year-over-year from 24.96% in Q1 2025, and down 1.0% quarter-over-quarter from 72.61% in Q4 2025.
AbbVie (ABBV) Gross Margin (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Gross Margin for 15 consecutive years, with 71.88% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 188.0% year-over-year to 71.88%; the TTM figure through Mar 2026 stood at 70.68% (down 2.0% YoY), while the FY2025 annual figure was 70.24%, up 24.0% from the prior year.
- Gross Margin retreated to 71.88% in Q1 2026 per ABBV's latest filing, from 72.61% in the prior quarter.
- Across five years, Gross Margin topped out at 72.61% in Q4 2025 and bottomed at 53.44% in Q3 2023.
- Historically, Gross Margin has averaged 68.38% across 5 years, with a median of 70.07% in 2022.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 1266 bps — and 2024, when it soared 1744 bps.
- AbbVie's Gross Margin stood at 72.42% in 2022, then dropped by 17 bps to 60.11% in 2023, then rose by 18 bps to 70.89% in 2024, then advanced by 2 bps to 72.61% in 2025, then declined by 1 bps to 71.88% in 2026.
- Business Quant data shows ABBV's Gross Margin at 71.88% in Q1 2026, 72.61% in Q4 2025, and 66.38% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|